bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2019: A M F J
2018: D N O S A J J M A

 
  Other news for:
Chlamydia
Infection
Sex
Sexually Transmitted Diseases
 Resources from HONselect
New Chlamydia Test Offers Rapid Results

By Robert Preidt

WEDNESDAY, Dec. 5, 2018 (HealthDay News) -- A new test for chlamydia can provide results within 30 minutes, potentially speeding up the start of treatment, researchers say.

The rapid test for the sexually transmitted disease (STD) means patients can receive treatment immediately, instead of having to wait for a follow-up appointment. This could help reduce the spread of the disease, according to researchers at Johns Hopkins University in Baltimore.

Called a "point-of-care" test, the screening gives accurate results 93 percent of the time for a positive result and 99 percent of the time for a negative result, the investigators found. The study was funded by the U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB).

"Point-of-care tests for STDs are making significant progress towards being highly sensitive, specific and easy to read within a short wait time," Tiffani Bailey Lash said in an institute news release. She is director of NIBIB programs in point-of-care technologies.

Study leader Charlotte Gaydos said the goal of point-of-care technology is to deliver quick results and give patients more options.

"A patient should be able to choose if he/she comes into a clinic, goes to a pharmacy, or takes a test at home for STD diagnosis; the bottom line is to encourage people to get tested," said Gaydos, a professor of infectious diseases.

People with STDs often don't have obvious symptoms, which means they can unknowingly spread the diseases. Currently, patients wait two to 14 days for STD test results, and those who have been tested have low rates of return to receive results, counseling and treatment.

Women with untreated chlamydia can develop pelvic inflammatory disease. In men, untreated chlamydia can cause urethral infection and complications such as swollen and tender testicles.

The Johns Hopkins team is collaborating on a clinical trial that could lead to the approval of a chlamydia and gonorrhea point-of-care test in the United States.

The need is urgent, the researchers said. Government health officials reported a 10 percent increase in STDs between 2016 and 2017.

The report was published in the November issue of the journal Sexually Transmitted Diseases.

More information

The U.S. Centers for Disease Control and Prevention has more on chlamydia.

SOURCE: U.S. National Institute of Biomedical Imaging and Bioengineering, news release, Nov. 30, 2018

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=740263

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Research Personnel
Therapeutics
Infection
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact